Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nuvectis Pharma, Inc.

Clinical trials sponsored by Nuvectis Pharma, Inc., explained in plain language.

Nuvectis Pharma, Inc. NVCT NASDAQ

A biopharmaceutical company developing precision medicines for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Terminated 1

Can a pill target Hard-to-Treat ovarian cancers?

Disease control Terminated

This early-stage trial is testing an experimental oral drug called NXP800 in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find the safest dose and schedule, and then to see if the drug shows promise in specif…

Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC